|
CanCOGeN Next Generation Sequencing (NGS)
|
Sequencing
|
SARS-CoV-2
|
Influenza, Respiratory Viruses and Coronaviruses
|
|
Cerebrospinal Fluid (CSF) Test Panel
|
Host Marker
|
Creutzfeldt-Jakob Disease (CJD)/Prions
|
Prion Diseases Section
|
|
Confirmation
|
Molecular Detection
|
Vancomycin-Resistant Enterococcus (VRE)
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Confirmation
|
Molecular Detection
|
Methicillin-resistant Staphylococcus aureus (MRSA)
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Confirmation and toxin test by PCR
|
Molecular Detection
|
Clostridioides difficile
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Confirmation of Staphylococcal toxins by PCR
|
Molecular Detection
|
Staphylococcus aureus
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Culture Identification
|
Identification
|
Neisseria meningitidis
|
Syphilis Diagnostics and Vaccine Preventable Bacterial Diseases
|
